<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">To capture rapidly emerging COVID-19 science, all publication types (eg, peer-reviewed research, editorials, and preprints) were included in this review. Evidence was identified primarily through a search for publications with a “treatment” tag in the National Library of Medicine’s LitCovid literature hub
 <xref rid="bib5" ref-type="bibr">
  <sup>5</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> through June 29, 2020. A review of citations within these articles identified additional relevant articles. Studies were selected if they contained clinical data on COVID-19 therapeutics with near-term availability. A clinical trial landscape assessment for emerging therapies was performed by searching ClinicalTrials.gov
 <xref rid="bib7" ref-type="bibr">
  <sup>7</sup>
 </xref> for recruiting/open interventional trials on June 29, 2020, using a condition/disease query of COVID-19, SARS-CoV-2, and 2019 novel coronavirus (2019-nCoV).
</p>
